Takashima Y, Kawamura H, Okadome K, et al. Enrichment of Bacteroides fragilis and enterotoxigenic Bacteroides fragilis in CpG island methylator phenotype (CIMP)-high colorectal carcinoma. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2024. doi:10.1016/j.cmi.2024.01.013
Sarnowski C, Huan T, Ma Y, et al. Multi-tissue epigenetic analysis identifies distinct associations underlying insulin resistance and Alzheimer’s disease at CPT1A locus. Clinical epigenetics. 2023;15(1):173. doi:10.1186/s13148-023-01589-4
Ang QY, Plichta D, Kim S, et al. Differential Impact of Smoking on Methylome and Transcriptome in Crohn’s Disease and Ulcerative Colitis. Inflammatory bowel diseases. 2023. doi:10.1093/ibd/izad268
Mendez-Dorantes C, Burns KH. LINE-1 retrotransposition and its deregulation in cancers: implications for therapeutic opportunities. Genes & development. 2023;37(21-24):948-967. doi:10.1101/gad.351051.123
Bevill SM, CasanÃ-Galdón S, Farran CAE, et al. Impact of supraphysiologic MDM2 expression on chromatin networks and therapeutic responses in sarcoma. Cell genomics. 2023;3(7):100321. doi:10.1016/j.xgen.2023.100321
Mas G, Man N, Nakata Y, et al. The SWI/SNF chromatin-remodeling subunit DPF2 facilitates NRF2-dependent antiinflammatory and antioxidant gene expression. The Journal of clinical investigation. 2023;133(13). doi:10.1172/JCI158419
Parodi L, Mayerhofer E, Narasimhalu K, et al. Social Determinants of Health and Cerebral Small Vessel Disease: Is Epigenetics a Key Mediator?. Journal of the American Heart Association. 2023:e029862. doi:10.1161/JAHA.123.029862
Chory EJ, Wang M, Ceribelli M, et al. High-throughput approaches to uncover synergistic drug combinations in leukemia. SLAS discovery : advancing life sciences R & D. 2023. doi:10.1016/j.slasd.2023.04.004